The North Chicago-based biopharma company has struck a deal with a rival that's been trying to encroach with a cheaper alternative to Humira, the top-selling drug in the world.
from nicholemhearn digest http://www.chicagobusiness.com/article/20170928/NEWS03/170929866/abbvie-buys-more-time-for-top-selling-humira?utm_source=NEWS03&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment